Survivin

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 3: Line 3:
== Function ==
== Function ==
-
'''Survivin''' or '''apoptosis inhibitor 4''' (IAP4) plays a dual role. It inhibits caspase activation and thus it inhibits apoptosis and promotes cell proliferation<ref>PMID:9850056</ref>. Survivin is part of the chromosomal passanger complex (CPC) which includes also [[Borealin]] and [[INCENP]] <ref>PMID:23175282</ref>.
+
'''Survivin''' or '''apoptosis inhibitor 4''' or '''baculoviral IAP repeat-containing protein 5''' (IAP4) plays a dual role. It inhibits caspase activation and thus it inhibits apoptosis and promotes cell proliferation<ref>PMID:9850056</ref>. Survivin is part of the chromosomal passanger complex (CPC) which includes also [[Borealin]] and [[INCENP]] <ref>PMID:23175282</ref>.
== Disease ==
== Disease ==

Revision as of 07:22, 14 April 2022

Structure of human survivin dimer (magenta and green) complex with histone H3 peptide (cyan) and Zn+2 ion (grey) (PDB code 3uig).

Drag the structure with the mouse to rotate

3D structures of survivin

Updated on 14-April-2022

References

  1. Tamm I, Wang Y, Sausville E, Scudiero DA, Vigna N, Oltersdorf T, Reed JC. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res. 1998 Dec 1;58(23):5315-20. PMID:9850056
  2. Carmena M, Wheelock M, Funabiki H, Earnshaw WC. The chromosomal passenger complex (CPC): from easy rider to the godfather of mitosis. Nat Rev Mol Cell Biol. 2012 Dec;13(12):789-803. doi: 10.1038/nrm3474. PMID:23175282 doi:http://dx.doi.org/10.1038/nrm3474
  3. Zaffaroni N, Costa A, Pennati M, De Marco C, Affini E, Madeo M, Erdas R, Cabras A, Kusamura S, Baratti D, Deraco M, Daidone MG. Survivin is highly expressed and promotes cell survival in malignant peritoneal mesothelioma. Cell Oncol. 2007;29(6):453-66. PMID:18032822
  4. Rodel F, Sprenger T, Kaina B, Liersch T, Rodel C, Fulda S, Hehlgans S. Survivin as a prognostic/predictive marker and molecular target in cancer therapy. Curr Med Chem. 2012;19(22):3679-88. PMID:22680927

Proteopedia Page Contributors and Editors (what is this?)

Michal Harel, Alexander Berchansky

Personal tools